QVT
BIIB icon

Quantitative Value Technologies’s Biogen BIIB Stock Holding History

Quantitative Value Technologies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$448K Sell
1,294
-16
-1% -$4.85K 0.74% 34
2021
Q1 		$366K Buy
+1,310
New +$353K 0.79% 57

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Quantitative Value Technologies's BIIB Position: Q2 2021 in Review

Quantitative Value Technologies reduced its Biogen (BIIB) stake by 1.2% in Q2 2021, selling an estimated $4.85K and leaving 1,294 shares worth $448K. The position accounts for 0.74% of the portfolio, ranked #34.

Quantitative Value Technologies first reported a position in BIIB in Q1 2021 and has held it in 2 quarters since. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Quantitative Value Technologies held 1,294 shares of Biogen worth $448K as of Q2 2021.
  • Quantitative Value Technologies sold 16 Biogen shares in Q2 2021, an estimated $4.85K.
  • Biogen made up 0.74% of Quantitative Value Technologies's portfolio in Q2 2021, its #34 holding.
  • Quantitative Value Technologies first reported a position in Biogen in Q1 2021 and has held it in 2 quarters since.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Quantitative Value Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.